Your weekly roundup of the latest news from Drug Topics®.
Pharmacy finances can suffer if owners are tripped up by these common pitfalls.
Independent pharmacists stand to gain—or lose—depending on what happens at the polls in November 2022.
It’s too late for retail chain pharmacies to engage in the preventive maintenance that would have spared them the worst of the Great Resignation.
Acid sphingomyelinase deficiency is a rare, progressive genetic disease associated with significant morbidity and mortality.
Recently published research reveals an important benefit for middle-aged and older adults: a reduction in ischemic stroke risk.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.